Lebrikizumab vs Other Systemic Monotherapies for Moderate to Severe Atopic Dermatitis: Network Meta-analysis of Short-term Efficacy. J of Skin [Internet]. 2025 Jan. 13 [cited 2025 Jun. 24];9(1):s517. Available from: https://skin.dermsquared.com/skin/article/view/3159